SRPT - I respect Chaudhry's view and this board took a survey on the subject of accelerated FDA approval a few months ago and split evenly 13 to 13 in yes/no voting .... the question is how the stock will react to no approval ? My hunch is that's how the decision will go and that the stock drops to around $20.